Covaxin Efficacy
-
{
- All
- News
- Videos
-
Covaxin 77.8% Effective In Phase 3 Trial Data: Sources
Coronavirus: Bharat Biotech's Covaxin is 77.8 per cent effective in protecting against COVID-19 - according to results of Phase III trial data approved by the DCGI's Subject Expert Committee - sources said on Tuesday afternoon.
-
Bharat Biotech Says Covaxin Shows 78% Efficacy Against Mild To Severe COVID-19
Bharat Biotech on Wednesday said its coronavirus vaccine Covaxin has shown efficacy of 78 per cent against mild, moderate and severe cases of COVID-19, as per Phase III interim analysis results.
-
Covaxin Maker Says It's 81% Effective. What Next? A 7-Point Guide
Today, Bharat Biotech, the company that makes Covaxin, said that new data shows it is 81 per cent effective in protecting against COVID-19. This is interim analysis of Phase 3 of its trial. What does this data mean?
-
Covaxin 81% Effective, Works Against UK Variant, Claims Bharat Biotech
Covaxin is 81 per cent effective in preventing Covid and can work against the UK variant of the virus, Bharat Biotech said Wednesday as it revealed a "first interim analysis" of Phase III trial results for a vaccine cleared in January amid concerns over safety and efficacy.
-
Covaxin 77.8% Effective In Phase 3 Trial Data: Sources
Coronavirus: Bharat Biotech's Covaxin is 77.8 per cent effective in protecting against COVID-19 - according to results of Phase III trial data approved by the DCGI's Subject Expert Committee - sources said on Tuesday afternoon.
-
Bharat Biotech Says Covaxin Shows 78% Efficacy Against Mild To Severe COVID-19
Bharat Biotech on Wednesday said its coronavirus vaccine Covaxin has shown efficacy of 78 per cent against mild, moderate and severe cases of COVID-19, as per Phase III interim analysis results.
-
Covaxin Maker Says It's 81% Effective. What Next? A 7-Point Guide
Today, Bharat Biotech, the company that makes Covaxin, said that new data shows it is 81 per cent effective in protecting against COVID-19. This is interim analysis of Phase 3 of its trial. What does this data mean?
-
Covaxin 81% Effective, Works Against UK Variant, Claims Bharat Biotech
Covaxin is 81 per cent effective in preventing Covid and can work against the UK variant of the virus, Bharat Biotech said Wednesday as it revealed a "first interim analysis" of Phase III trial results for a vaccine cleared in January amid concerns over safety and efficacy.
